Eli Lilly's head of obesity talks weight-loss innovations for 2025 — from an Ozempic-like pill to a triple-threat shot
Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...
Eli Lilly CEO expects new weight loss pill to be approved next year
Eli Lilly expects its experimental weight loss pill, orforglipron, to be approved as soon as early next year, CEO David Ricks ...
Everyday Health2y
Weight Loss Pills, Past and Present: How They Work, Safety, and More
The weight loss medications ... In the SURMOUNT-1 trial, participants using the highest dose lost an average of 22.5 percent of their body weight. This combination pill works to suppress ...